Your browser doesn't support javascript.
loading
A Kinase Inhibitor with Anti-Pim Kinase Activity is a Potent and Selective Cytotoxic Agent Toward Acute Myeloid Leukemia.
Bjørnstad, Ronja; Aesoy, Reidun; Bruserud, Øystein; Brenner, Annette K; Giraud, Francis; Dowling, Tara Helen; Gausdal, Gro; Moreau, Pascale; Døskeland, Stein Ove; Anizon, Fabrice; Herfindal, Lars.
Afiliação
  • Bjørnstad R; Department of Clinical Science, Centre for Pharmacy, University of Bergen, Bergen, Norway.
  • Aesoy R; Hospital Pharmacy in western Norway, Bergen.
  • Bruserud Ø; Department of Clinical Science, Centre for Pharmacy, University of Bergen, Bergen, Norway.
  • Brenner AK; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Giraud F; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Dowling TH; Université Clermont Auvergne, CNRS, Sigma Clermont, ICCF, F-63000 Clermont-Ferrand, France.
  • Gausdal G; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Moreau P; BerGenBio AS, Bergen, Norway.
  • Døskeland SO; Université Clermont Auvergne, CNRS, Sigma Clermont, ICCF, F-63000 Clermont-Ferrand, France.
  • Anizon F; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Herfindal L; Université Clermont Auvergne, CNRS, Sigma Clermont, ICCF, F-63000 Clermont-Ferrand, France.
Mol Cancer Ther ; 18(3): 567-578, 2019 03.
Article em En | MEDLINE | ID: mdl-30679386
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carbazóis / Leucemia Mieloide Aguda / Inibidores de Proteínas Quinases / Indazóis Limite: Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Noruega
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carbazóis / Leucemia Mieloide Aguda / Inibidores de Proteínas Quinases / Indazóis Limite: Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Noruega